The Insight Series: AI & Digital Health
“The Insight Series: AI & Digital Health” features industry experts answering key questions to help inform policymakers and the public about how AI is shaping the future of care delivery.…
Health Access
Resources, insights, and events focused on improving access to care, reducing disparities, and supporting inclusive innovation across the health care system. Learn more about our Health Access work.
AdvaMed® and Informa’s LSX Portfolio Announce Strategic Global Partnership to Advance Medtech Innovation and Collaboration
WASHINGTON—AdvaMed®, The Medtech Association®, today announced a strategic event partnership with Informa, the global events leader and owner of the LSX portfolio of life sciences conferences, to strengthen collaboration across…
AdvaMed® Announces Opening Nominations for its 2026 Lifetime Achievement, Dx Lifetime of Leadership & Service, and theAdvaMed® Imaging Röntgen Awards
WASHINGTON—AdvaMed® announced today that nominations for its 2025 Lifetime Achievement Award as well as the AdvaMedDx Lifetime of Leadership & Service Award and theAdvaMed® Imaging Röntgen Award are open through April 10. All three of these…
Heart Month: Why Sleep Apnea Belongs at the Center of Cardiovascular Care
February is American Heart Month—a time to spotlight cardiovascular disease and highlight innovations that can improve patient outcomes. For the medtech community, it’s an opportunity to address persistent gaps in…
The Insight Series: AI & Digital Health
AdvaMed® Digital Health Tech division member companies include world leaders in developing AI-enabled solutions to improve health and care, from diagnosis to treatment, clinical decision support, and wearables to wellness.…
Why the Health Tech Investment Act Matters: Peter Weems Breaks Down What This Means for Patients
In a new video developed in partnership with Patients Rising, AdvaMed’s Peter Weems, Vice President of Imaging Government Affairs and Policy Strategy, explains why the Health Tech Investment Act is critical to expanding patient…
Catalyst OrthoScience Receives FDA 510(k) Clearance for Expanded Indications of the Fracture Shoulder System
NAPLES, Fla., Dec. 4, 2025 – Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology company redefining shoulder arthroplasty through simplified, surgeon-focused innovation, today announced that its Catalyst Fracture Shoulder System has received…
Francis Medical Receives FDA 510(k) Clearance for Use of the Vanquish® Water Vapor System for Prostate Tissue Ablation in Patients with Intermediate Risk Prostate Cancer
MINNEAPOLIS (Dec. 2, 2025) – Francis Medical, Inc., a privately-held medical device company developing the breakthrough Vanquish® Water Vapor Ablation System for the management of prostate cancer, today announced that…
AdvaMed® Urges CMS to Protect Patient Access to Critical Medical Equipment
WASHINGTON — AdvaMed, the MedTech Association®, the world’s largest trade association representing medtech innovators, today released the following statement on the U.S. Centers for Medicare & Medicaid Services’ (CMS) release…
AdvaMed® Applauds House Introduction of the Health Tech Investment Act
WASHINGTON – AdvaMed, the MedTech Association®, today commended Representatives John Joyce, M.D. (R-PA), Beth Van Duyne (R-TX), Jay Obernolte (R-CA), Brad Schneider (D-IL), Scott Peters (D-CA) and Angie Craig (D-MN)…